SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study

AIMS/HYPOTHESIS: Insulin is the primary treatment for type 1 diabetes. However, alternative glucose-lowering therapies are used adjunctively, but importantly are off-label in type 1 diabetes. Little work has previously been undertaken to evaluate safety with long-term efficacy and cardio-renal benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Anson, Matthew, Zhao, Sizheng S., Austin, Philip, Ibarburu, Gema H., Malik, Rayaz A., Alam, Uazman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473989/
https://www.ncbi.nlm.nih.gov/pubmed/37505282
http://dx.doi.org/10.1007/s00125-023-05975-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473989/
https://www.ncbi.nlm.nih.gov/pubmed/37505282
http://dx.doi.org/10.1007/s00125-023-05975-8

Ejemplares similares